Stay Updated with the Latest John B. Sanfilippo & Son, Inc. JBSS News in Real Time
Find JBSS news now at Meyka AI. Stay informed with the latest John B. Sanfilippo & Son, Inc. stocks updates, including price news, market analysis, and expert insights.
Liontrust (LON: LIO) Shares Jump 12% as Operating Margin Beats Forecast at 24%
Introduction Liontrust Asset Management (LON: LIO) delivered one of its strongest single-session moves in years on June 24, 2026. Liontrust stock surged 12.4% to reach 330.4p after the independent fund manager published its annual results for the financial year ended March 31, 2026, delivering an adjusted operating margin of 24% ahead of the analyst consensus…
Top Google Gemini Researchers Jonas Adler & Alexander Pritzel Exit for Anthropic Amid Ongoing AI Brain Drain
The battle for top AI talent is becoming one of the biggest stories in the artificial intelligence industry. Google has invested billions of dollars in AI research, custom chips, and Gemini models, yet the company is now facing another high-profile talent loss. Jonas Adler & Alexander Pritzel, two researchers viewed internally as important contributors to…
Liontrust (LON: LIO) Rises 12% After Outflows Narrow to £276M in Current Quarter
Liontrust shares surged about 12% in late June 2026 after the UK asset manager reported quarterly net outflows of £276 million, a sharp improvement from previous periods. The update gave investors fresh confidence that the company’s long struggle with client withdrawals may be starting to ease. While outflows have not disappeared, the trend is moving…
Nike Inc (NYSE: NKE) Stock Drops Ahead of Q4 Earnings as Surprise CFO Change Raises Turnaround Questions
Nike Inc chose the worst possible timing for a leadership change. Nike Inc (NYSE: NKE) announced on June 23, 2026, that CFO Matthew Friend will step down effective August 17, to be replaced by David M. Denton as incoming Chief Financial Officer. NKE traded near $45.20 as of June 15, already 44% below its 52-week…
New Zealand shares -0.26% S&P/NZX 50 Index, Nvidia -4%, AMD -6% Nasdaq Composite -2%, S&P 500 -1%
Global markets faced fresh pressure on June 24, 2026, as a sharp selloff in semiconductor stocks rattled investor sentiment. NVIDIA fell around 4%, while AMD dropped nearly 6%, dragging the Nasdaq Composite down about 2% and the S&P 500 lower by 1%. The weakness also spread to Asia, with New Zealand’s S&P/NZX 50 Index slipping…
Qualcomm Inc (NASDAQ: QCOM) Loses 1.86% to $221.90 as AI Expansion Gains Momentum but Stock Faces Pressure
Qualcomm Inc (NASDAQ: QCOM) pulled back 1.86% to $221.90 on June 23, 2026, even as its AI and automotive expansion story grows more concrete by the quarter. The stock trades within a 52-week range of $121.99 to $259.92, reflecting a sharp recovery from lows but still well off its all-time closing high of $250.10 from…
Tesla Inc Shares (NASDAQ: TSLA) up +1.14% After Jefferies Lowers Target to $375 Amid SpaceX Merger Talk
Tesla Inc. shares climbed 1.14% after analysts at Jefferies lowered their price target to $375, drawing fresh attention to the company’s future growth path. The move comes as investors closely watch rising speculation about a possible Tesla-SpaceX merger, a topic that has sparked intense debate across Wall Street in June 2026. While some see major…
Robinhood (NASDAQ: HOOD) Shares Slide 4% After Unveiling $2 Billion Convertible Notes Offering Due 2029
Robinhood shares dropped roughly 4% on June 22, 2026, after the company announced a major capital raise before market open. Robinhood Markets, Inc. (NASDAQ: HOOD) intends to offer $2.0 billion in convertible senior notes due 2029 in a private placement to qualified institutional buyers under Rule 144A. Shares traded at $108.15 on June 22, within…
AbbVie to Acquire Apogee Therapeutics in $10.9 Billion Deal, Offering Nearly 50% Premium
AbbVie made a major move in the biotech sector on June 22, 2026, announcing a $10.9 billion deal to acquire Apogee Therapeutics. The transaction offers Apogee shareholders nearly a 50% premium and gives AbbVie access to a promising pipeline of immunology treatments. As competition grows in the market for inflammatory disease therapies, this acquisition could…